Akagera Medicines
Developer of novel liposomal formulations of antibacterial drugs intended to treat tuberculosis. The company develops novel liposomal formulations of antibacterial drugs to treat tuberculosis and othe...
Valuation
$345M
Latest known
Share Price
N/A
Total Raised
$62.2M
Last Round
N/A